| 股號 / 名稱 | 總負債 | 淨值 |
| MDT 美敦力 | 1,352,109,211,082.07 | 1,540,865,468,502.47 |
| NVO 諾和諾德 | 1,737,915,964,075.59 | 966,697,851,775.02 |
| SYK 史賽克 | 805,191,122,257.76 | 710,052,901,235.8 |
| ZBH Zimmer Biomet Holdings Inc | 339,872,110,152.19 | 404,004,898,956.94 |
| PHG Koninklijke Philips NV | 586,769,331,581.65 | 392,195,476,458.45 |
| BIO Bio Rad Laboratories Inc | 93,732,050,245.2 | 213,357,911,911.03 |
| RMD 瑞思邁 | 69,120,609,566.06 | 200,185,480,477.72 |
| NVST Envista Holdings Corp | 80,895,991,330.36 | 97,804,878,215.72 |
| ICUI ICU Medical Inc | 62,569,722,306.64 | 67,371,098,757.98 |
| NEOG Neogen Corp | 39,761,220,590.99 | 66,650,214,541.3 |
| QDEL QuidelOrtho Corp | 115,239,495,616.71 | 64,493,832,652.84 |
| EYE National Vision Holdings Inc | 34,828,411,510.75 | 27,197,401,405.81 |
| INMD Inmode Ltd | 2,572,279,065.05 | 20,693,038,129.97 |
| TGTX TG Therapeutics Inc | 13,232,130,350.3 | 19,230,905,556.76 |
| ATRC AtriCure Inc | 5,033,552,982.07 | 15,091,221,133.33 |
| WRBY Warby Parker Inc | 10,682,337,349.48 | 11,706,213,363.93 |
| BLFS BioLife Solutions Inc | 1,214,310,809.06 | 11,203,095,594.57 |
| QTRX Quanterix Corp | 4,104,688,506.58 | 9,961,453,132.8 |
| PAHC Phibro Animal Health Corp | 34,009,158,680.72 | 9,871,097,159.24 |
| MRVI Maravai LifeSciences Holdings Inc | 19,121,008,876.69 | 7,773,305,719.8 |
| ORMP Oramed Pharmaceuticals Inc | 545,081,199.07 | 6,438,045,221.63 |
| VALN Valneva SE | 11,066,810,794.77 | 5,592,911,174.28 |
| VMD Viemed Healthcare Inc | 2,177,411,109.09 | 4,231,433,899.57 |
| UTMD Utah Medical Products Inc | 117,909,319.86 | 3,745,101,502.09 |
| CAPR Capricor Therapeutics Inc | 1,348,243,824.97 | 2,656,119,147.27 |
| MGNX MacroGenics Inc | 6,453,247,067.87 | 2,121,956,040.84 |
| CERS Cerus Corp | 4,868,454,597.85 | 1,946,564,739.9 |
| INFU InfuSystem Holdings Inc | 1,374,816,968.9 | 1,756,795,026.07 |
| ZVIA Zevia PBC | 277,402,023.28 | 1,623,113,790.74 |
| RMTI Rockwell Medical Inc | 648,168,718.85 | 1,172,442,390.89 |
| ICCC ImmuCell Corp | 504,488,469.16 | 943,807,890.33 |
| VERU Veru Inc | 364,307,494.45 | 580,605,063.38 |
| XGN Exagen Inc | 1,415,196,872.96 | 574,439,764.61 |
| MYO Myomo Inc | 616,050,068.1 | 463,199,621.38 |
| SNES Senestech Inc | 103,752,600.56 | 359,396,981.41 |
| UG United-Guardian Inc | 50,606,629.41 | 335,151,303.49 |
| PHGE Biomx Inc | 496,656,984.71 | 332,096,999.21 |
| NEPH Nephros Inc | 102,644,132.6 | 316,895,152.98 |
| CLRB Cellectar Biosciences Inc | 166,215,086.5 | 297,048,192.6 |
| CTSO Cytosorbents Corp | 1,163,257,942.12 | 285,668,027.17 |
| APYX Apyx Medical Inc | 1,631,569,817.71 | 185,209,159.97 |
| IMCC IM Cannabis Corp | 918,799,011.64 | 90,197,936.12 |
| GCTK GlucoTrack Inc | 175,422,971.45 | 87,125,581.24 |
| EOLS Evolus Inc | 7,846,591,286.86 | -910,843,953.59 |
| OMER Omeros Corp | 12,864,055,648.33 | -6,982,651,363.01 |
| BRBR Bellring Brands Inc | 49,754,375,907.29 | -16,174,130,983.99 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例